MediWound (MDWD) Depreciation & Amortization (CF) (2013 - 2025)

MediWound's Depreciation & Amortization (CF) history runs 13 years deep, the most recent figure standing at $418000.0 for Q3 2025.

• On a quarterly basis, Depreciation & Amortization (CF) rose 15.79% year-over-year to $418000.0 in Q3 2025; TTM through Dec 2025 was $1.2 million, a 21.11% decrease from a year earlier, with the FY2024 full-year figure at $1.5 million, up 13.81% from the prior year.
• Depreciation & Amortization (CF) climbed to $418000.0 in Q3 2025 per MDWD's latest filing, from $394000.0 in the prior quarter.
• Across five years, Depreciation & Amortization (CF) topped out at $418000.0 in Q3 2025 and bottomed at $276000.0 in Q4 2021.
• The 5-year median for Depreciation & Amortization (CF) is $338000.0 (2022), against an average of $341000.0.
• Across the five-year window, Depreciation & Amortization (CF) rose 23.21% in 2021 and retreated 5.61% in 2023, its largest moves.
• Year by year, Depreciation & Amortization (CF) stood at $276000.0 in 2021, then advanced by 2.9% to $284000.0 in 2022, then grew by 21.83% to $346000.0 in 2023, then climbed by 14.74% to $397000.0 in 2024, then grew by 5.29% to $418000.0 in 2025.
• Per Business Quant, the three latest MDWD Depreciation & Amortization (CF) figures stand at $418000.0 (Q3 2025), $394000.0 (Q2 2025), and $358000.0 (Q1 2025).